| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 09/02/2004 | US20040171068 Method for producing stable, regeneratable antibody arrays |
| 09/02/2004 | US20040171067 Identifying modulators of g protein coupled receptor activity for diagnosing, treating and preventing disorders associated with cholesterol metabolism, cancer, infections and inflammation |
| 09/02/2004 | US20040171064 Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
| 09/02/2004 | US20040171063 Local descriptors of protein structure |
| 09/02/2004 | US20040171057 Electro-optical devices and methods for hybridization and detection |
| 09/02/2004 | US20040171053 Solid support comprising microparticles with known addresses for use in analysis of gene expression, drug discovery and disease diagnostics |
| 09/02/2004 | US20040171052 Using intracellular expression of cytokines to prognosis outcomes of viral, cell proliferative and inflammatory diseases and/or drug therapies |
| 09/02/2004 | US20040171045 Assay for predicting cell activity |
| 09/02/2004 | US20040171042 Functional assays that use theT1R1 receptor to screen for T1R1-associated taste modulators |
| 09/02/2004 | US20040171040 Detectable labeled nucleoside analogs and methods of use thereof |
| 09/02/2004 | US20040171039 Loop probe hybridization assay for polynucleotide analysis |
| 09/02/2004 | US20040171036 Levels of Pin1 in normal and cancerous tissue |
| 09/02/2004 | US20040171035 Methods and compositions for modulating P53 transcription factor |
| 09/02/2004 | US20040171034 for aiding in proteomic analysis wherein kinase and phosphatase substrates and enzymes can be identified; solid phase synthesis; kits |
| 09/02/2004 | US20040171026 Diagnostic method for transmissible spongiform encephalopathies |
| 09/02/2004 | US20040171021 Diagnosing cell proliferative disorders via enhanced expression of migration inhibitory factor proteins; serum-based test for accurate detection and prognosis of tumor disorders |
| 09/02/2004 | US20040171015 Cyp450-specific dna probes and primers, and biological applications thereof |
| 09/02/2004 | US20040171014 Quinacridone derivatives as labelling reagents for flurescence detection of bilogical materials |
| 09/02/2004 | US20040171013 Using variation in complement receptor gene expression (CR-1) to differentiate between bacterial and viral infection |
| 09/02/2004 | US20040171012 Nucleic acid-associated proteins |
| 09/02/2004 | US20040171011 Immobilized asymmetric double lipid layers |
| 09/02/2004 | US20040171007 Using oligonuclleotide and DNA amplification to identify mycobacterium in biological samples; clinical diagnostics |
| 09/02/2004 | US20040171001 Comprises cationic, water-soluble polythiophene derivatives, which can readily transduce oligonucleotide hybridization into a clearly interpretable optical (colorimetric, fluorescent or luminescent) or electrical signal |
| 09/02/2004 | US20040170999 Nuclear hormone receptor ligand binding domain |
| 09/02/2004 | US20040170995 for drug screening in vitro for mitogen-activated protein kinase-activated protein kinase-2 modulators using expression libraries; genetic engineering; kits |
| 09/02/2004 | US20040170989 Cellular gene targets for controlling cell growth |
| 09/02/2004 | US20040170988 Modified solid carrier and DNA detection device |
| 09/02/2004 | US20040170982 Novel therapeutic targets in cancer |
| 09/02/2004 | US20040170973 DNA encoding the human serine protease EOS |
| 09/02/2004 | US20040170972 comprises DNA vaccine, a recombinant vaccine, and a T cell epitope vaccine; includes use of serological diagnosis; genetic engineering |
| 09/02/2004 | US20040170971 kits for detecting amplification or elevated expression for diagnosis; genetic engineering; solid phase synthesis |
| 09/02/2004 | US20040170970 Split- ubiquitin based reporter systems and methods of their use |
| 09/02/2004 | US20040170967 Assays for detection of bacillus anthracis |
| 09/02/2004 | US20040170966 Continuous time-resolved resonance energy-transfer assay for polynucleic acid polymerases |
| 09/02/2004 | US20040170965 Mixed cell diagnostic systems |
| 09/02/2004 | US20040170964 Composition and method for regulating the adhesion of cells and biomolecules to hydrophobic surfaces |
| 09/02/2004 | US20040170961 for drug screening anticancer agents; solid phase synthesis; animal models; genetic engineering; kits |
| 09/02/2004 | US20040170953 comprises using a phosphate buffer that specifically binds to hepatitis B virus; genetic engineering; kits |
| 09/02/2004 | US20040170949 Method for organizing and depicting biological elements |
| 09/02/2004 | US20040170820 Multimetallic nanofillers with domain size less than 100 nanometers exhibiting transparency to visible light that differs by more than 20% as compared to fillers having a domain size of at least one micron. |
| 09/02/2004 | US20040170757 Method for depositing a spot product of a product of interest, and use for isolating and/or determining an analyte |
| 09/02/2004 | US20040170653 recognised by CD8-positive cytotoxic T-lymphocytes as a peptide antigen and causes a CTL-induced lysis and/or apoptosis of tumor or leukemia cell; has the amino acid sequence LLGDLFGV, which corresponds to the amino acid positions 81 to 88 of the hdm2 proto-oncoprotein |
| 09/02/2004 | US20040170651 In vivo modulation of neuronal transport |
| 09/02/2004 | US20040170644 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof |
| 09/02/2004 | US20040170641 Prevention and treatment of amyloidogenic disease |
| 09/02/2004 | US20040170637 Use of rmLT as a marker antigen for vaccines and as a synergistic adjuvant with AMPHIGEN |
| 09/02/2004 | US20040170634 Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors |
| 09/02/2004 | US20040170631 Heparanase activity neutralizing anti-heparanase monoclonal antibody and other anti-heparanase antibodies |
| 09/02/2004 | US20040170629 Marker proteins for diagnosing smooth muscle cell abnormalities |
| 09/02/2004 | US20040170626 and inhibits IL-2 binding to CD25; can be produced by a hybridoma, a transfectoma or in a nonhuman transgenic animal; treating diseases including organ, tissue and cell transplant rejection, autoimmune diseases, inflammatory and hyperproliferative skin disorders, and lymphoid neoplasms |
| 09/02/2004 | US20040170624 active principle, especially the humanized monoclonal antibody JAQ1, that induces irreversible inactivation or degradation of the collagen receptor on thrombocytes; diagnostic agent for the determination of the expression rate of the collagen receptor GPVI |
| 09/02/2004 | US20040170622 Methods and compositions for modulating XBP-1 activity |
| 09/02/2004 | US20040170611 culturing an autologous or allogenic dermal papilla cell in the presence of a Wnt polypeptide or a fragment or analog thereof, and grafting the cultured cell onto the skin |
| 09/02/2004 | US20040170535 Testing tool; recovering blood serum without hemolysis; separation porous membrane |
| 09/02/2004 | US20040170530 Measuring variations between signals; determination physical properties; calibration |
| 09/02/2004 | US20040169864 Method for determining the paper quality for halftone printing |
| 09/02/2004 | US20040169502 Method and apparatus for evaluating measuring signals |
| 09/02/2004 | US20040169142 Method for analyzing organic material per microscopic area, and device for analysis per microscopic area |
| 09/02/2004 | US20040169139 Chemical monitoring method and apparatus, and incinerator |
| 09/02/2004 | US20040168916 Miniature device for separating and isolation biological objects and uses thereof |
| 09/02/2004 | US20040168912 Microelectronics, layouts; measuring current, voltage; plasma membranes; forming apertures in polymer by flowing air, then curing |
| 09/02/2004 | US20040168644 Milking |
| 09/02/2004 | US20040168529 Methods and systems for dissolution testing |
| 09/02/2004 | US20040168525 Tensiometer, drive probe for use with environmental testing equipment, and methods of inserting environmental testing equipment into a sample |
| 09/02/2004 | DE19932601B4 Verfahren zur Bestimmung der Temperatur und/oder der Viskosität einer Glasschmelze Method for determining the temperature and / or the viscosity of a glass melt |
| 09/02/2004 | DE10307793A1 Method for detecting and removing endotoxins, useful for treating e.g. recombinantly produced pharmaceuticals or nucleic acid, by incubation with phage tail protein |
| 09/02/2004 | DE10307517A1 Von Kapsidantigenen des Epstein-Barr-Virus abgeleitete Peptide und ihre Verwendung Kapsidantigenen of the Epstein-Barr virus-derived peptides and their use |
| 09/02/2004 | DE10307390A1 For the cellular testing of a number of substances, e.g. molecular bonds with DNA and proteins and peptides, spots are placed in micro-arrays without physical separation for biological assay |
| 09/02/2004 | DE10303080A1 Monitor to measure gas emitted from an organic body, to set optimum training for stamina sports or monitor a driver's sleepiness, has a shrouding attached to part of the body surface covering a gas sensor in the gas phase |
| 09/02/2004 | DE10297227T5 Verbesserung bei oder bezüglich des Nachweises von beeinträchtigter Fruchtbarkeit Improvements in or relating to the detection of impaired fertility |
| 09/02/2004 | DE102004007392A1 Gaskonzentrationsdetektor Gas concentration detector |
| 09/02/2004 | DE10026789B4 Knorpelersatz und Verfahren zu dessen Herstellung Cartilage replacement and process for its preparation |
| 09/02/2004 | CA2833559A1 Treatment of conditions associated with decreased nitric oxide bioavailability, including elevated arginase conditions |
| 09/02/2004 | CA2787820A1 Glycoprotein antigen sima135 expressed in metastatic human tumor cells |
| 09/02/2004 | CA2714863A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2519320A1 Method of estimating antitumor effect of histone deacetylase inhibitor |
| 09/02/2004 | CA2516484A1 Methods for the prediction of suicidality during treatment |
| 09/02/2004 | CA2516454A1 Methods for treating pain by administering a nerve growth factor antagonist and an nsaid and compositions containing the same |
| 09/02/2004 | CA2516377A1 Quantification of botulinum toxin |
| 09/02/2004 | CA2516371A1 Method of diagnosis of type 2 diabetes and early onset thereof |
| 09/02/2004 | CA2516335A1 A method of diagnosis and treatment |
| 09/02/2004 | CA2516290A1 Methods of diagnosis and prognosis of pancreatic cancer |
| 09/02/2004 | CA2516284A1 Methods of constructing biodiverse gene fragment libraries and biological modulators isolated therefrom |
| 09/02/2004 | CA2516191A1 Compositions and methods for the detection and treatment of methylthioadenosine phosphorylase deficient cancers |
| 09/02/2004 | CA2516138A1 Therapeutic gpcr targets in cancer |
| 09/02/2004 | CA2516128A1 Therapeutic targets in cancer |
| 09/02/2004 | CA2516029A1 Method of measuring homocysteine |
| 09/02/2004 | CA2515783A1 Statistically identifying an increased risk for disease |
| 09/02/2004 | CA2515777A1 Biphenyl derivatives |
| 09/02/2004 | CA2515576A1 Devices for component removal during blood collection, and uses thereof |
| 09/02/2004 | CA2513591A1 Microarray devices having controllable reaction volume |
| 09/02/2004 | CA2498650A1 Mycobacterial diagnostics |
| 09/01/2004 | EP1452885A1 Method of evaluating green malt qualities by electron spin resonance spectrometry and method of evaluating malt qualities |
| 09/01/2004 | EP1452868A2 Method for selecting a candidate drug compound |
| 09/01/2004 | EP1452865A1 Composition for blood serum or plasma separation and vessel for blood examination containing the same |
| 09/01/2004 | EP1452862A1 Gas sensitive field effect transistor comprising a gas sensitive layer and method of producing the same |
| 09/01/2004 | EP1452860A1 Sensing element for measuring ammonia and corresponding method |
| 09/01/2004 | EP1452859A1 Method and sensing element for measuring a gas in a gas mixture |
| 09/01/2004 | EP1452857A1 Biosensor |
| 09/01/2004 | EP1452856A1 Biosensor |